These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32885760)

  • 1. miRNAs Modulate the Dichotomy of Cisplatin Resistance or Sensitivity in Breast Cancer: An Update of Therapeutic Implications.
    Safi A; Bastami M; Delghir S; Ilkhani K; Seif F; Alivand MR
    Anticancer Agents Med Chem; 2021; 21(9):1069-1081. PubMed ID: 32885760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer.
    Chen Y; Gao Y; Zhang K; Li C; Pan Y; Chen J; Wang R; Chen L
    Cell Physiol Biochem; 2015; 37(5):1869-80. PubMed ID: 26584286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNAs-mediated cisplatin resistance in breast cancer.
    Chen X; Lu P; Wu Y; Wang DD; Zhou S; Yang SJ; Shen HY; Zhang XH; Zhao JH; Tang JH
    Tumour Biol; 2016 Oct; 37(10):12905-12913. PubMed ID: 27448297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
    Pogribny IP; Filkowski JN; Tryndyak VP; Golubov A; Shpyleva SI; Kovalchuk O
    Int J Cancer; 2010 Oct; 127(8):1785-94. PubMed ID: 20099276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
    Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
    Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microRNAs in breast cancer stem cells.
    Schwarzenbacher D; Balic M; Pichler M
    Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
    Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
    Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
    Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs.
    Ahmad A; Maitah MY; Ginnebaugh KR; Li Y; Bao B; Gadgeel SM; Sarkar FH
    J Hematol Oncol; 2013 Oct; 6(1):77. PubMed ID: 24199791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
    Chekhun VF; Borikun TV; Lukianova NY
    Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
    Ye Z; Hao R; Cai Y; Wang X; Huang G
    Tumour Biol; 2016 Apr; 37(4):4509-15. PubMed ID: 26503209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
    Wang X; Zhu J
    Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.
    He X; Xiao X; Dong L; Wan N; Zhou Z; Deng H; Zhang X
    Tumour Biol; 2015 Mar; 36(3):2065-75. PubMed ID: 25394901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.
    Uhr K; Prager-van der Smissen WJC; Heine AAJ; Ozturk B; van Jaarsveld MTM; Boersma AWM; Jager A; Wiemer EAC; Smid M; Foekens JA; Martens JWM
    PLoS One; 2019; 14(5):e0216400. PubMed ID: 31063487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs.
    Farhan M; Malik A; Ullah MF; Afaq S; Faisal M; Farooqi AA; Biersack B; Schobert R; Ahmad A
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNA deregulation in breast cancer cell chemoresistance and stemness.
    Tekiner TA; Basaga H
    Curr Med Chem; 2013; 20(27):3358-69. PubMed ID: 23651304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.